Introduction Seminar About Patient Participation and Treatment Options for Psychiatric Patients on Waiting List
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00967265|
Recruitment Status : Completed
First Posted : August 27, 2009
Last Update Posted : June 14, 2017
Patient participation is a central concept in Norwegian health policy. It is mandatory in hospitals and emphasised as one of the most prioritised areas by the Government. Studies from Norway have repeatedly found that patients who seek help in community mental health centres ("DPS") are dissatisfied with the information they receive and about their possibility for real influence in their treatment.
One way to improve individual patient participation might be to give patients information before they start their treatment. This can be done as group based patient education to reduce the resources needed. Furthermore, as there are waiting lists for treatment, such introduction seminars could be held while patients are waiting to use this time in a meaningful way.
The present study therefore aims at testing the effect of an introduction seminar for patients on waiting list in a community mental health centre.
|Condition or disease||Intervention/treatment||Phase|
|Mental Disorders||Behavioral: Introduction seminar Other: Usual care||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||92 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Introduction Seminar About Patient Participation and Treatment Options for Patients on Waiting List in a Community Mental Health Centre - Development, Effect, Experiences and Costs|
|Study Start Date :||June 2009|
|Actual Primary Completion Date :||June 2011|
|Actual Study Completion Date :||July 2012|
Experimental: Introduction seminar
Psychoeducation for patients on waiting list
Behavioral: Introduction seminar
The seminar will be held over two half days, each lasting 2.5 hours. Up to 30 patients can participate in each seminar. The details of the content of the program will be developed based on study one. The preliminarily plans are to give general information about the community mental health centre, the available treatment options and patients rights by presentations from health personnel and user representatives. At the end of each day, the patients will be divided into small groups mentored by health personnel were they can discuss the presentations and ask questions. In the breaks, literature and other type of information for patients will be on display. All participants will get a folder with details of the program and leaflets from patient organisations and governmental agencies.
Other Name: psychoeducation
Active Comparator: Usual care
Other: Usual care
- Behavior and symptoms [ Time Frame: 12 months ]Behavior and Symptom Identification Scale (BASIS-32)
- knowledge on treatment preference [ Time Frame: 1 month ]
- patient activation (coping) [ Time Frame: 4 months ]measured with Patient Activation Measure (PAM)
- Client satisfaction [ Time Frame: Baseline, 4 and 12 months ]Satisfaction measured with Client Satisfaction Questionnaire (CSQ-8)
- Perceived participation [ Time Frame: Baseline, 4 and 12 months ]Perceived participation measured with Perception of care (PoC)
- Psychiatric Out-Patient Experiences [ Time Frame: Baseline, 4 and 12 months ]Psychiatric Out-Patient Experiences Questionnaire (POPEQ)
- Quality of Life [ Time Frame: Baseline, 4 and 12 months ]WHO-5
- motivation for treatment [ Time Frame: Baseline, 1 and 4 months ]motivation for treatment (questions)
- costs [ Time Frame: Baseline, 1, 4 and 12 months ]data on health care use, sick leave, medication and other direct and indirect costs will be collected
- Knowledge [ Time Frame: Baseline, 1, 4 and 12 months ]measured using a self developed questionnaire
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00967265
|Trondheim, Norway, 7055|
|Principal Investigator:||Aslak Steinsbekk, PhD||Norwegian University of Science and Technology|